Back Dictionary Export CSV
Filter: Clear
MERGED_REGIMEN_ID MERGED_TUMOUR_ID HEIGHT_AT_START_OF_REGIMEN WEIGHT_AT_START_OF_REGIMEN INTENT_OF_TREATMENT DATE_DECISION_TO_TREAT START_DATE_OF_REGIMEN MAPPED_REGIMEN CLINICAL_TRIAL CHEMO_RADIATION MERGED_PATIENT_ID BENCHMARK_GROUP
220014082 220008569 1.76 85 Curative (C) 2014-03-04 2014-04-11 AML Int Guide ADE 8+3+5 (2) N N 220032351 ADE
220014083 220008571 1.68 124.4 Not known (9) 2015-03-21 2015-03-23 BOSUTINIB 02 Y 220032353 BOSUTINIB
220014084 220008571 1.7 null Curative (C) 2014-07-28 2014-07-28 Triple Intrathecal 02 N 220032353 TRIPLE INTRATHECAL
220014085 220008572 null 21.45 Curative (C) null 2016-09-05 Methotrexate intrathecal Y N 220032358 METHOTREXATE INTRATHECAL
220014087 220008574 null 74 Curative (C) 2013-07-21 2013-07-21 BOSUTINIB N N 220032371 BOSUTINIB
220014088 220008576 1.55 70.9 Adjuvant (A) 2012-09-27 2014-05-07 Idarubicin+Tretinoin Spanish Crse2 N N 220032372 IDARUBICIN + TRETINOIN
220014089 220008577 1.58 59.3 Curative (C) 2013-10-13 2013-10-16 AML Int Guide ADE 8+3+5 (2) N N 220032378 ADE
220014090 220008580 1.83 88 Curative (C) 2015-11-05 2015-12-25 BOSUTINIB Y N 220032380 BOSUTINIB
220014091 220008581 1.6 68 null null 2017-02-19 RUXOLITINIB N N 220032382 RUXOLITINIB
220014092 220014634 1.9 71.8 Palliative (P) 2013-05-19 2013-05-29 RUXOLITINIB N N 220032382 RUXOLITINIB
220014093 220008583 1.77 8.8 Adjuvant (A) 2015-03-28 2015-04-02 Cyclophosphamide+Fludara+TBI Allo N N 220032386 CYCLOPHOSPHAMIDE + FLUDARABINE
220014094 220008584 1.55 55 Disease modification (D) 2013-09-17 2013-09-17 Cyclophosphamide TBI Allograft N N 220032392 CYCLOPHOSPHAMIDE
220014095 220014635 1.85 106.8 Curative (C) 2017-06-29 2017-06-29 BOSUTINIB N N 220032392 BOSUTINIB
220014096 220008585 1.64 null Palliative (P) 2014-07-29 2014-07-29 Methotrexate intrathecal N N 220032405 METHOTREXATE INTRATHECAL
220014097 220008587 1.85 119 null 2017-09-15 2017-09-22 IDARUBICIN + TRETINOIN N N 220032407 IDARUBICIN + TRETINOIN
220014098 220008587 1.66 14.8 Adjuvant (A) 2014-12-10 2015-01-26 RUXOLITINIB N null 220032407 RUXOLITINIB
220014099 220008588 1.76 71.8 Curative (C) 2014-01-15 2014-01-19 Triple Intrathecal N Y 220032418 TRIPLE INTRATHECAL
220014100 220008591 0 57.3 Disease modification (D) null 2016-12-24 RUXOLITINIB 02 N 220032418 RUXOLITINIB
220014101 220008593 1.53 null Curative (C) 2017-08-04 2017-08-06 Cyclophosphamide+Fludara+TBI Allo N N 220032423 CYCLOPHOSPHAMIDE + FLUDARABINE
220014102 220008594 1.6 75 Palliative (P) 2016-11-17 2016-12-28 Methotrexate intrathecal Y N 220032429 METHOTREXATE INTRATHECAL
220014103 220014641 1.55 56.7 Curative (C) 2013-08-18 2013-08-31 Methotrexate intrathecal N N 220032429 METHOTREXATE INTRATHECAL
220014104 220008595 1.8 109 Disease modification (D) 2015-11-18 2015-11-28 BOSUTINIB 02 N 220032447 BOSUTINIB
220014105 220008596 1.7 null Curative (C) 2013-05-13 2013-05-26 Triple Intrathecal N N 220032460 TRIPLE INTRATHECAL
220014106 220008597 0 77.1 Palliative (P) 2016-07-09 2016-07-09 AML Int Guide ADE 8+3+5 (2) 2 N 220032464 ADE
220014110 220008604 1.62 57.7 Curative (C) 2013-07-12 2013-07-21 Triple Intrathecal N N 220032476 TRIPLE INTRATHECAL
220014111 220008607 1.54 0 Palliative (P) 2015-08-09 2015-09-06 CYCLOPHOSPHAMIDE + FLUDARABINE N N 220032495 CYCLOPHOSPHAMIDE + FLUDARABINE
220014112 220008608 1.83 90.8 Palliative (P) 2015-07-03 2015-07-10 BOSUTINIB 2 N 220032496 BOSUTINIB
220014113 220008609 1.77 73.7 Adjuvant (A) 2015-12-24 2015-12-24 AML16 DA 3+8 N N 220032501 AML16 TRIAL
220014114 220008609 1.83 61.5 Disease modification (D) 2012-10-11 2012-10-17 AML16 DA 3+8 N N 220032501 AML16 TRIAL
220014115 220008609 1.68 75 Curative (C) 2013-12-17 2015-03-14 RUXOLITINIB 02 N 220032501 RUXOLITINIB
220014116 220008609 null 74.9 Palliative (P) 2018-01-12 2018-01-13 Idarubicin+Tretinoin Spanish Crse4 02 N 220032501 IDARUBICIN + TRETINOIN
220014118 220008611 1.63 56 Not known (9) 2013-10-05 2013-10-05 BOSUTINIB N null 220032519 BOSUTINIB
220014119 220008612 0 92.6 Curative (C) 2015-09-13 2015-09-15 RUXOLITINIB N N 220032520 RUXOLITINIB
220014120 220008612 1.6 null Not known (9) 2015-08-01 2015-08-02 AML16 DA 3+10 N N 220032520 AML16 TRIAL
220014121 220008613 null 58.5 null 2015-10-31 2015-11-03 AML Int Guide ADE 10+3+5 (1) N N 220032522 ADE
220014122 220008614 1.59 58.5 Curative (C) 2015-06-18 2015-06-19 FLAG Y N 220032524 FLAG
220014123 220008617 1.73 112 Curative (C) null 2015-06-30 FLAG Y N 220032527 FLAG
220014124 220008618 1.7 83.2 Curative (C) 2018-01-20 2018-01-20 CYCLOPHOSPHAMIDE + FLUDARABINE Y N 220032527 CYCLOPHOSPHAMIDE + FLUDARABINE
220014125 220008619 1.64 73 Disease modification (D) 2015-10-02 2015-11-22 BOSUTINIB N N 220032532 BOSUTINIB
220014126 220008626 1.71 68.8 Curative (C) 2013-07-09 2013-08-26 Cyclophosphamide+Fludara+TBI Allo N N 220032533 CYCLOPHOSPHAMIDE + FLUDARABINE
220014127 220008626 1.81 60 Palliative (P) 2014-12-22 2014-12-22 IDARUBICIN + TRETINOIN N N 220032533 IDARUBICIN + TRETINOIN
220014128 220008626 0 null Curative (C) 2015-07-30 2015-07-30 Idarubicin+Tretinoin Spanish Crse2 N N 220032533 IDARUBICIN + TRETINOIN
220014129 220008627 1.75 null Curative (C) 2013-05-19 2014-06-14 FLAG N N 220032555 FLAG
220014130 220008627 1.83 79 Disease modification (D) 2014-11-03 2014-11-19 Methotrexate intrathecal N N 220032555 METHOTREXATE INTRATHECAL
220014131 220008629 1.78 102.9 Curative (C) 2017-06-06 2017-06-14 BOSUTINIB null Y 220032572 BOSUTINIB
220014132 220008630 0.99 null Disease modification (D) 2015-01-21 2015-02-02 FLAG N N 220032574 FLAG
220014133 220008630 null 80 Curative (C) 2015-02-10 2015-03-21 FLAG Y N 220032574 FLAG
220014134 220008631 null 98.75 Disease modification (D) null 2014-11-26 Triple / Double Intrathecal Therapy null null 220032589 TRIPLE INTRATHECAL
220014135 220008632 1.78 68 null 2014-01-18 2014-01-19 Cyclophosphamide+Fludara+TBI Allo N N 220032602 CYCLOPHOSPHAMIDE + FLUDARABINE
220014136 220008636 1.55 21.5 Curative (C) 2016-01-30 2016-02-04 Cyclophosphamide TBI Allograft 02 null 220032603 CYCLOPHOSPHAMIDE